• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Veralipride Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5758524

MBS5758524 is an inhibitor targeting Veralipride. Veralipride is an antagonist of D2 receptor. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Veralipride, Inhibitor
Full Product Name
Veralipride
Product Synonym Names
(+/-)-Veralipride; LIR166
Form/Format
Solid. Powder
Purity/Purification
99.21%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
383.46
Solubility
DMSO: 100mg/mL (260.78mM)
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C17H25N3O5S
SMILES
C=CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)cc(OC)c1OC
CAS Number
66644-81-3
Target & IC50
D2
In Vitro
Veralipride significantly increased dehydroepiandrosterone sulfate and estradiol levels. High values of prolactin were found, and some patients showed slight breast discharge; these changes disappeared 48 hours after the drug was stopped[1].

Product References and Citations for Veralipride, inhibitor

David A, Don R, Tajchner G, et al. Veralipride: alternative antidopaminergic treatment, for menopausal symptoms[J]. Maturitas, 1988, 10(4):354-354.
David A, Don R, Tajchner G, et al. Veralipride: alternative antidopaminergic treatment, for menopausal symptoms[J]. Maturitas, 1988, 10(4):354-354.
Melis G B, Gambacciani M, Cagnacci A, et al. Effects of the Dopamine Antagonist Veralipride on Hot Flushes and Luteinizing Hormone Secretion in Postmenopausal Women[J]. Obstetrics and Gynecology, 1988, 72(5).
Melis G B, Gambacciani M, Cagnacci A, et al. Effects of the Dopamine Antagonist Veralipride on Hot Flushes and Luteinizing Hormone Secretion in Postmenopausal Women[J]. Obstetrics and Gynecology, 1988, 72(5).

Other Notes

Small volumes of Veralipride, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000